|
|
News Breaks | | | | November 15, 2012 | | 13:44 EDT |  | DVAX | FDA panel votes against backing Dynavax's Heplisav, Bloomberg reports
An FDA panel voted against recommending approval of Dynavax's hepatitis B vaccine Heplisav, saying the company provided inadequate safety data, Bloomberg reports. | |
|
News For DVAX From The Last 14 Days Check below for free stories on DVAX the last two weeks. |
|
|
| There are no results for DVAX |
|
|
|
|
|
|
